Odd, coming from pre-commercialization biopharmaceutical...but I guess they see value in repurchasing their stock with the market being so hammered down.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.